NQO2 Antibodies

Santa Cruz Biotechnology provides a broad selection of NQO2 monoclonal antibodies for research focused on NAD(P)H:quinone oxidoreductase 2. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NQO2 plays a critical role in cellular defense against oxidative stress by catalyzing the reduction of quinones and protecting cells from damage. The enzyme actively participates in metabolizing various drugs and environmental toxins, making it particularly relevant for pharmacology and toxicology research. Understanding NQO2 function is essential for uncovering its role in various diseases, including cancer and neurodegenerative disorders. Research involving NQO2 continues to reveal new insights about cellular protection mechanisms and potential therapeutic targets. Investigating NQO2 expression patterns helps identify its involvement in different cellular pathways and stress responses. Current studies focusing on NQO2 are advancing our understanding of drug metabolism and cellular defense mechanisms. Santa Cruz Biotechnology monoclonal antibodies for NQO2 research support scientists worldwide in advancing therapeutic strategies and expanding our understanding of cellular protection mechanisms.